Aprea Therapeutics, Inc. (APRE)
NASDAQ·Healthcare·Biotechnology
$0.78
+5.94%
Mkt Cap $5.40M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.78
+5.94%
Mkt Cap $5.40M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —